ÂÜÀòÂÒÂ×

Lydia Cai is an experienced professional with a strong background in healthcare and finance. Currently serving as a Board Member at Dingdang Health Technology Group and Kangji Medical, Lydia also contributes to Novotech, Zhaoke Ophthalmology, and previously Bioheart as a Board Member. With a decade-long tenure at TPG, Lydia has held various roles including Managing Director, Principal, Vice President, and Associate. Prior experience includes an Associate position at Hao Capital and a Research Analyst role at Credit Suisse, focusing on Large Cap Medical Supplies & Devices. Lydia holds a Bachelor of Arts in Biomedical Engineering and Economics from Yale University and completed a junior term abroad in Economics at Université Paris Dauphine - PSL.